Literature DB >> 15380937

PKC-interacting proteins: from function to pharmacology.

Alastair W Poole1, Giordano Pula, Ingeborg Hers, David Crosby, Matthew L Jones.   

Abstract

Protein kinase C (PKC) is a ubiquitously expressed family of kinases that have key roles in regulating multiple cellular activities. The activity of this family is controlled tightly by several molecular mechanisms, including interaction with binding-partner proteins. These PKC-interacting proteins (C-KIPs) confer specificity for individual PKC isoforms by regulating the activity and cellular localization of PKC isoforms and, subsequently, the ability of these isoforms to specifically regulate cellular functional events. Although many C-KIPs have been identified by genome and proteome-mining approaches, it is important to address the specificity and function of the interactions in greater detail because they might form novel drug targets. In this article, we review recent work on C-KIPs and the implications for pharmacological and therapeutic development.

Mesh:

Substances:

Year:  2004        PMID: 15380937     DOI: 10.1016/j.tips.2004.08.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  32 in total

Review 1.  PKC in developmental hypothyroid rat brain.

Authors:  Hong-Mei Zhang; Qing Su
Journal:  Neurol Sci       Date:  2014-03-29       Impact factor: 3.307

2.  Conformationally constrained analogues of diacylglycerol. 29. Cells sort diacylglycerol-lactone chemical zip codes to produce diverse and selective biological activities.

Authors:  Dehui Duan; Dina M Sigano; James A Kelley; Christopher C Lai; Nancy E Lewin; Noemi Kedei; Megan L Peach; Jeewoo Lee; Thushara P Abeyweera; Susan A Rotenberg; Hee Kim; Young Ho Kim; Saïd El Kazzouli; Jae-Uk Chung; Howard A Young; Matthew R Young; Alyson Baker; Nancy H Colburn; Adriana Haimovitz-Friedman; Jean-Philip Truman; Damon A Parrish; Jeffrey R Deschamps; Nicholas A Perry; Robert J Surawski; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2008-08-13       Impact factor: 7.446

Review 3.  Atypical protein kinase Cι as a human oncogene and therapeutic target.

Authors:  Peter J Parker; Verline Justilien; Philippe Riou; Mark Linch; Alan P Fields
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

Review 4.  Cardiac sodium channel mutations: why so many phenotypes?

Authors:  Man Liu; Kai-Chien Yang; Samuel C Dudley
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

5.  Green tea polyphenols precondition against cell death induced by oxygen-glucose deprivation via stimulation of laminin receptor, generation of reactive oxygen species, and activation of protein kinase Cε.

Authors:  Usha Gundimeda; Thomas H McNeill; Albert A Elhiani; Jason E Schiffman; David R Hinton; Rayudu Gopalakrishna
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

6.  Overexpression of atypical protein kinase C in HeLa cells facilitates macropinocytosis via Src activation.

Authors:  Ellen J Tisdale; Assia Shisheva; Cristina R Artalejo
Journal:  Cell Signal       Date:  2014-02-27       Impact factor: 4.315

7.  Antiapoptotic effects of vasopressin in the neuronal cell line H32 involve protein kinase Calpha and beta.

Authors:  Jun Chen; Ying Liu; Jae-Won Soh; Greti Aguilera
Journal:  J Neurochem       Date:  2009-06-10       Impact factor: 5.372

Review 8.  Redox signaling and protein phosphorylation in mitochondria: progress and prospects.

Authors:  D Brian Foster; Jennifer E Van Eyk; Eduardo Marbán; Brian O'Rourke
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

Review 9.  Protein kinase Calpha: disease regulator and therapeutic target.

Authors:  Olga Konopatskaya; Alastair W Poole
Journal:  Trends Pharmacol Sci       Date:  2009-12-05       Impact factor: 14.819

10.  Brain endothelial cell-cell junctions: how to "open" the blood brain barrier.

Authors:  Svetlana M Stamatovic; Richard F Keep; Anuska V Andjelkovic
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.